Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Gilenya® (fingolimod) – New warning
November 20, 2018 - The FDA announced that a warning about the potential risk of severe increase in disability when Gilenya (fingolimod) therapy is stopped will be added to the Gilenya drug label and patient Medication Guide.
